TVGN
Tevogen Bio Holdings Inc.
7.30$
-7.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -13.5% | -38.9% | -1.6% | +29.6% | -19.3% | +17.7% | +4.8% | +5.3% | -2.5% | +12.3% | -3.9% | |
| – | -37.7% | +39.3% | +2.0% | +44.2% | -33.1% | +30.4% | -33.0% | +3.0% | -27.4% | +39.0% | -6.2% | |
| – | -59.6% | +25.2% | -13.8% | +105.3% | -45.0% | +53.9% | -65.3% | +51.3% | -46.7% | +25.3% | +56.3% | |
| – | -59.6% | +25.2% | -13.8% | +105.3% | – | – | -65.3% | +51.3% | -46.7% | +25.3% | +56.3% | |
| – | – | -53.9% | +0.0% | +0.0% | – | – | +0.0% | +0.0% | +0.0% | – | – | |
| – | +2.9% | -90.8% | +19.4% | -4.2% | -3.3% | +16.4% | +16.6% | -10.4% | +2.4% | +17.0% | -7.8% | |
| – | +26.3% | -89.5% | +18.7% | -1.8% | -13.2% | -3.6% | -7.3% | -16.6% | +4.9% | +2.8% | -15.4% | |
| – | +26.4% | -97.6% | +0.4% | +52.2% | – | – | +8.6% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | +81.3% | +52.5% | +27.9% | -12.4% | -10.9% | -10.3% | -9.1% | -21.9% | +0.9% | +13.7% | -25.5% | |
| – | – | – | – | – | – | +200.0% | +46.7% | +0.0% | +0.0% | +45.5% | +0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.3% | -12.0% | +8.3% | +10.4% | +4.6% | -9.3% | +14.2% | +6.4% | -15.3% | +5.0% | +9.8% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.